Adamis Pharmaceuticals CEO Dennis Carlo's 2021 pay slips 20% to $783K
Adamis Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: July 7, 2022
Adamis Pharmaceuticals reported fiscal year 2021 executive compensation information on July 7, 2022.
In 2021, four executives at Adamis Pharmaceuticals received on average a compensation package of $665K, a 3% decrease compared to previous year.
Average pay of disclosed executives at Adamis Pharmaceuticals
Dennis J. Carlo, Chief Executive Officer, received $783K in total, which decreased by 20% compared to 2020. 88% of Carlo's compensation, or $687K, was in salary. Carlo also received $96K in other compensation.
Ronald B. Moss, Chief Medical Officer, received a compensation package of $693K, which increased by 13% compared to previous year. 68% of the compensation package, or $474K, was in salary.
Robert O. Hopkins, Chief Financial Officer, earned $691K in 2021, a 19% increase compared to previous year.
David J. Marguglio, Chief Business Officer, received $491K in 2021, which decreases by 11% compared to 2020.
Related executives
You may also like
Source: SEC filing on July 7, 2022.